The Global Immunotherapy Drugs Market, which was valued at USD 246.00 billion in 2023, is projected to reach a staggering USD 829.78 billion by 2032, growing at a compound annual growth rate (CAGR) of 14.49% over the forecast period from 2024 to 2032. This exponential growth trajectory underscores the increasing demand for advanced immunotherapy treatments across a wide range of chronic...